Mandatory notification of exercise of warrants and sale of shares to primary insider’s related party
Nykode Therapeutics ASA (NYKD) · publisert 31. mars 2022 kl. 23:30 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Einar J. Greve | – | Utøvelse Opsjonsutøvelse | 150 000 | 18 NOK | 31. mars 2022 | NO0010714785 | Outside of trading venue |
| Einar J. Greve | – | Salg Opsjonsutøvelse | 150 000 | 43,75 NOK | 31. mars 2022 | NO0010714785 | Outside of trading venue |
| Einar J. Greve | – | Kjøp Opsjonsutøvelse | 150 000 | 43,75 NOK | 31. mars 2022 | NO0010714785 | Outside of trading venue |
Vedlegg
- Attachment 220331.pdf (application/pdf, originaldokument)
Meldingstekst
Primary insider Einar J. Greve, member of the board of Nykode Therapeutics AS, has today exercised 150,000 warrants with expiry date of March 31, 2022. The shares have been sold to Cipriano AS, which is 100% owned by Einar J. Greve.
Please see further details in attached document.